Citadel Advisors’s GMO Beyond China ETF BCHI Stock Holding History

Citadel Advisors’s Portfolio BCHI Stock Details BCHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743K	Sell	18,807 -1,774	-9%	-$67.7K	﹤0.01%	8924
2026 Q1	$656K	Sell	20,581 -310	-1%	-$10.2K	﹤0.01%	8638
2025 Q4	$638K	Buy	+20,891	New	+$626K	﹤0.01%	8428
2025 Q3	–	Sell	-17,977	Closed	-$492K	–	14526
2025 Q2	$492K	Buy	17,977 +1,037	+6%	+$26.4K	﹤0.01%	8672
2025 Q1	$412K	Buy	+16,940	New	+$418K	﹤0.01%	8908

Other funds holding BCHI

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CMP

Coston McIsaac & Partners Bar Harbor, Maine $497M AUM 11% 1-Year Est. Return

Citadel Advisors's BCHI Position: Q2 2026 in Review

Citadel Advisors reduced its GMO Beyond China ETF (BCHI) stake by 8.6% in Q2 2026, selling an estimated $67.7K and leaving 18,807 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #8924.

Citadel Advisors first reported a position in BCHI in Q1 2025 and has held it in 5 quarters since. 5 funds tracked by Wall St. Rank hold BCHI as of Q2 2026.

Citadel Advisors held 18,807 shares of GMO Beyond China ETF worth $743K as of Q2 2026.
Citadel Advisors sold 1,774 GMO Beyond China ETF shares in Q2 2026, an estimated $67.7K.
GMO Beyond China ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8924 holding.
Citadel Advisors first reported a position in GMO Beyond China ETF in Q1 2025 and has held it in 5 quarters since.
5 funds tracked by Wall St. Rank held GMO Beyond China ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.